DCA Vantage® Analyzer

Drive diabetic patient compliance with trusted, clinically proven results.

Provide the clinical confidence your patients deserve. The DCA Vantage® Analyzer helps you monitor glycemic control and detect early kidney disease in environments ranging from the physician’s clinic to remote, point-of-care coordinated sites in hospitals and multisite practices.

Monitor glycemic control and diabetes complications using an analyzer designed to make consultations easier. Fast, actionable test results enable you to determine the effectiveness of a treatment plan, make therapeutic adjustments with confidence, and be more certain whether patients are complying with your recommendations

    • Manage diabetes patients more effectively.
    • Improve workflow in clinic.
    • Simplify management of diabetes testing in decentralized settings.

For detailed Features & Benefits, visit here


Intended Use
The DCA Vantage® Analyzer is a semi-automated, bench top system. It is designed to quantitatively measure the percent of Haemoglobin A1c in blood and low concentrations of albumin in urine (microalbuminuria), creatinine in urine, and the albumin/creatinine ratio in urine. The DCA Vantage® Analyzer is intended for professional use in a physician’s clinic or hospital laboratory. Tests performed using the DCA Vantage® Analyzer are intended for professional in vitro diagnostic use at the point of care.